Connect with others who understand.

sign up log in
About MyPsoriasisTeam
PSORIASIS
NEWS

Serious Infection Risks Lower for People With Psoriatic Arthritis Than Rheumatoid Arthritis After TNF Inhibitor Treatment

Posted on December 24, 2021
See how 43 members reacted on this article
Medically reviewed by
Ariel D. Teitel, M.D., M.B.A.
Article written by
Aminah Wali, Ph.D.

  • Tumor necrosis factor (TNF) inhibitors — a type of biologic — are effective treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but they can increase the risk of serious infection.
  • People with RA are more likely than people with PsA to have a serious infection following treatment with TNF inhibitors, according to a recent study.
  • Risk factors among people with RA, including more frequent use of prednisolone, may contribute to the increased risk of infection, researchers noted.

Following TNF inhibitor treatment, people with RA develop serious infections at nearly twice the rate as those with PsA, according to a recent research study. The findings may help guide health care providers in how they prescribe TNF inhibitors — a type of biologic — for people with different types of rheumatological conditions.

The study was published in Annals of the Rheumatic Diseases and used data collected by the NORwegian-Disease Modifying Anti-Rheumatic Drug (NOR-DMARD) registry, a large collection of information about responses to drug treatments over time.

RA and PsA are both forms of arthritis, an autoimmune disease that affects the joints. Autoimmune diseases arise when the immune system, which normally protects the body from infection, malfunctions and attacks the body’s own tissues. Whereas RA isn’t always linked to another disease, PsA specifically occurs in people with psoriasis.

Response to TNF Inhibitors

Rheumatoid arthritis and psoriatic arthritis may be treated with a class of drugs called tumor necrosis factor inhibitors, which helps to prevent the autoimmune response by making the immune system weaker. While this alleviates symptoms of arthritis, TNF inhibitors can increase the chance of serious infections, such as gastrointestinal (GI) and subcutaneous tissue (the deepest layer of skin) infections.

Examples of TNF inhibitors used to treat psoriatic arthritis include Cimzia (certolizumab pegol), Enbrel (etanercept), and Humira (adalimumab). The research study does not identify specific TNF inhibitors used to treat RA or PsA.

Researchers sought to determine whether one form of arthritis had a higher risk of serious infection after using TNF inhibitors compared to the other. To perform this comparison, the research team used information collected by the NOR-DMARD between 2009 and 2018 that looked at how people with RA and PsA responded to TNF inhibitors.

The treatment data from the NOR-DMARD was then connected to the Norwegian Patient Registry and the Norwegian Cause of Death Registry to identify people who had had a serious infection — a diagnosed infection that resulted in a hospital stay or death.

The study found that, across the same age and gender, people with PsA were less likely than people with RA to have a serious infection at 12 and 24 months after starting treatment with TNF inhibitors. The incidence rate for serious infections was significantly lower in people with PsA (2.16) compared to the rate in people with RA (4.17). Incidence rates are the total number of cases in a given time period divided by the total number of persons in the population.

The study presents an important finding regarding risk of serious infection among people in treatment for PsA, which has not been as well studied as RA. The conclusion is further supported by the use of real clinical data collected from several hospitals.

Researchers suggested reasons why people with RA may be at higher risk of developing infections after TNF inhibitor treatment. “The additive effect of multiple risk factors in the RA population, including more frequent prednisolone use, may explain some of the increased risk of [serious infections] in patients with RA. Another explanation could be the RA disease itself, through disease-related alterations in host defence.”

The authors noted, however, that the study results “need to be interpreted with caution given the many important differences between the RA and PsA population,” including possible effects from other medications people may take.

Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here.

Recent news

The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast)...
Posted 01/12/2022

Otezla Now Approved for All Severity Levels of Psoriasis

The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast)...
Posted 01/12/2022
Research shows that individuals with psoriasis or psoriatic arthritis (PsA) are more likely to...
Posted 01/11/2022

Sexual Dysfunction and Depression Rates Are Higher Among People With Psoriasis and PsA, Study Finds

Research shows that individuals with psoriasis or psoriatic arthritis (PsA) are more likely to...
Posted 01/11/2022
On a recent podcast, representatives of the National Psoriasis Foundation (NPF) and Hemophilia...
Posted 01/05/2022

Critics of Step Therapy Warn It May Lead to Worse Health Outcomes

On a recent podcast, representatives of the National Psoriasis Foundation (NPF) and Hemophilia...
Posted 01/05/2022
Lately I have been wondering about my biological treatment for psoriasis and when (if ever) to...
Posted 01/04/2022

Can I Ever Stop Taking My Biologic for Psoriasis?

Lately I have been wondering about my biological treatment for psoriasis and when (if ever) to...
Posted 01/04/2022
A recent review of several existing studies highlights how inflammation is related to both...
Posted 12/30/2021

Psoriasis and Alzheimer’s Disease Are Linked By Chronic Inflammation and Genetics

A recent review of several existing studies highlights how inflammation is related to both...
Posted 12/30/2021
The Society for Pediatric Dermatology has released a virtual handout about psoriasis for...
Posted 12/29/2021

Nonprofit Releases Guides for Teachers and Nurses To Support Students With Skin Conditions

The Society for Pediatric Dermatology has released a virtual handout about psoriasis for...
Posted 12/29/2021
A recent study found that people with psoriasis would like their health care providers to use a “...
Posted 12/28/2021

Individuals With Psoriasis Would Prefer ‘Biologic Calculator’ To Help Guide Treatment Decisions

A recent study found that people with psoriasis would like their health care providers to use a “...
Posted 12/28/2021
Women with psoriatic arthritis (PsA) face higher risks during pregnancy, including greater...
Posted 12/22/2021

Women With Psoriatic Arthritis Face More Risks During Pregnancy

Women with psoriatic arthritis (PsA) face higher risks during pregnancy, including greater...
Posted 12/22/2021
I had anxiety and depression long before I first experienced psoriasis. They are an expected part...
Posted 12/21/2021

The Relationship Between My Anxiety and Psoriasis

I had anxiety and depression long before I first experienced psoriasis. They are an expected part...
Posted 12/21/2021
People with psoriasis who take immunosuppressant drugs develop normal levels of antibodies from a...
Posted 12/17/2021

Immunosuppressants for Psoriasis May Reduce Effectiveness of COVID-19 Vaccine, Study Finds

People with psoriasis who take immunosuppressant drugs develop normal levels of antibodies from a...
Posted 12/17/2021
psoriasis News

Become a Subscriber

Get the latest news about psoriasis sent to your inbox.

Not now, thanks

Privacy policy
psoriasis News

Thank you for signing up.

close